Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

DGCR6L 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00085359-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-DGCR6L full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 24.9
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-DGCR6L antibody (H00085359-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00085359-T01
    DGCR6L transfected lysate.
    Western Blot
    QC Testing of H00085359-T01
    Lane 1: DGCR6L transfected lysate ( 24.9 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • DGCR6L
  • Gene Alias:
  • FLJ10666
  • Gene Description:
  • DiGeorge syndrome critical region gene 6-like
  • Gene Summary:
  • This gene, the result of a duplication at this locus, is one of two functional genes encoding nearly identical proteins that have similar expression patterns. The product of this gene is a protein that shares homology with the Drosophila gonadal protein, expressed in gonadal tissues and germ cells, and with the human laminin gamma-1 chain that functions in cell attachment and migration. This gene is located in a region of chromosome 22 implicated in the DiGeorge syndrome, one facet of a broader collection of anomalies referred to as the CATCH 22 syndrome. [provided by RefSeq
  • Other Designations:
  • DiGeorge syndrome critical region gene 6 like
  • RSS
  • YouTube
  • Linkedin
  • Facebook